Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Classical hematology 4

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Thrombosis 1Embolism 1

Interventions

apixaban 22Rivaroxaban 16Dalteparin 16Enoxaparin 11Heparin, Low-Molecular-Weight 10Tinzaparin 8Aspirin 8Fondaparinux 4Dabigatran 4edoxaban 3Warfarin 3Nadroparin 3bemiparin 2abelacimab 2Rosuvastatin Calcium 2Observation 2MAA868 2sotorasib 1ribociclib 1reviparin 1palbociclib 1isoquercitrin 1enoxaparin sodium 1certoparin 1calcium heparin 1betrixaban 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Venous Thromboembolism × Dabigatran × Classical hematology × Clear all
NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting
1 enrolled
Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Bayer

Completed
97,765 enrolled
Classical hematology

Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡